Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers

Francesca Brambilla, Mario Lampertico, Alberto E. Panerai, Laura Sali, Francesco Salerno, Eugenio E. Müller

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Neuroendocrine effects of intravenous injections of clonidine, 0.15 mg, were investigated in 13 heroin addicts and 14 normal control subjects. The study was designed to determine whether continuous opiate administration leads to the development of hypersensitive α2-adrenergic receptors. The peak increments in levels of plasma growth hormone (GH) and β-endorphin induced by clonidine did not differ between heroin addicts and normal control subjects. At no time interval could the clonidine-induced rise in GH levels in addicts be differentiated from that induced by placebo. Clonidine failed to alter plasma prolactin, gonadotropin, or thyrotropin levels in either heroin addicts or controls. Since clonidine's neuroendocrine effects are reportedly due to the activation of postsynaptic α2-adrenoceptors, it appears that (1) continuous opiate use does not lead to the development of hypersensitive α2-adrenergic receptors involved in neuroendocrine mechanisms and (2) brain norepinephrine does not play a role in the regulation of tonic prolactin, gonadotropin, and thyrotropin secretion in man.

Original languageEnglish
Pages (from-to)295-304
Number of pages10
JournalPsychiatry Research
Volume13
Issue number4
DOIs
Publication statusPublished - 1984

Fingerprint

Anterior Pituitary Hormones
Heroin
Clonidine
Healthy Volunteers
Opiate Alkaloids
Adrenergic Receptors
Thyrotropin
Gonadotropins
Prolactin
Growth Hormone
Endorphins
Intravenous Injections
Norepinephrine
Placebos
Brain

Keywords

  • clonidine
  • growth hormone
  • Heroin addicts
  • β-endorphin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Brambilla, F., Lampertico, M., Panerai, A. E., Sali, L., Salerno, F., & Müller, E. E. (1984). Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. Psychiatry Research, 13(4), 295-304. https://doi.org/10.1016/0165-1781(84)90077-5

Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. / Brambilla, Francesca; Lampertico, Mario; Panerai, Alberto E.; Sali, Laura; Salerno, Francesco; Müller, Eugenio E.

In: Psychiatry Research, Vol. 13, No. 4, 1984, p. 295-304.

Research output: Contribution to journalArticle

Brambilla, F, Lampertico, M, Panerai, AE, Sali, L, Salerno, F & Müller, EE 1984, 'Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers', Psychiatry Research, vol. 13, no. 4, pp. 295-304. https://doi.org/10.1016/0165-1781(84)90077-5
Brambilla, Francesca ; Lampertico, Mario ; Panerai, Alberto E. ; Sali, Laura ; Salerno, Francesco ; Müller, Eugenio E. / Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. In: Psychiatry Research. 1984 ; Vol. 13, No. 4. pp. 295-304.
@article{32467d81c2b74c5cb27ce9819883a965,
title = "Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers",
abstract = "Neuroendocrine effects of intravenous injections of clonidine, 0.15 mg, were investigated in 13 heroin addicts and 14 normal control subjects. The study was designed to determine whether continuous opiate administration leads to the development of hypersensitive α2-adrenergic receptors. The peak increments in levels of plasma growth hormone (GH) and β-endorphin induced by clonidine did not differ between heroin addicts and normal control subjects. At no time interval could the clonidine-induced rise in GH levels in addicts be differentiated from that induced by placebo. Clonidine failed to alter plasma prolactin, gonadotropin, or thyrotropin levels in either heroin addicts or controls. Since clonidine's neuroendocrine effects are reportedly due to the activation of postsynaptic α2-adrenoceptors, it appears that (1) continuous opiate use does not lead to the development of hypersensitive α2-adrenergic receptors involved in neuroendocrine mechanisms and (2) brain norepinephrine does not play a role in the regulation of tonic prolactin, gonadotropin, and thyrotropin secretion in man.",
keywords = "clonidine, growth hormone, Heroin addicts, β-endorphin",
author = "Francesca Brambilla and Mario Lampertico and Panerai, {Alberto E.} and Laura Sali and Francesco Salerno and M{\"u}ller, {Eugenio E.}",
year = "1984",
doi = "10.1016/0165-1781(84)90077-5",
language = "English",
volume = "13",
pages = "295--304",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers

AU - Brambilla, Francesca

AU - Lampertico, Mario

AU - Panerai, Alberto E.

AU - Sali, Laura

AU - Salerno, Francesco

AU - Müller, Eugenio E.

PY - 1984

Y1 - 1984

N2 - Neuroendocrine effects of intravenous injections of clonidine, 0.15 mg, were investigated in 13 heroin addicts and 14 normal control subjects. The study was designed to determine whether continuous opiate administration leads to the development of hypersensitive α2-adrenergic receptors. The peak increments in levels of plasma growth hormone (GH) and β-endorphin induced by clonidine did not differ between heroin addicts and normal control subjects. At no time interval could the clonidine-induced rise in GH levels in addicts be differentiated from that induced by placebo. Clonidine failed to alter plasma prolactin, gonadotropin, or thyrotropin levels in either heroin addicts or controls. Since clonidine's neuroendocrine effects are reportedly due to the activation of postsynaptic α2-adrenoceptors, it appears that (1) continuous opiate use does not lead to the development of hypersensitive α2-adrenergic receptors involved in neuroendocrine mechanisms and (2) brain norepinephrine does not play a role in the regulation of tonic prolactin, gonadotropin, and thyrotropin secretion in man.

AB - Neuroendocrine effects of intravenous injections of clonidine, 0.15 mg, were investigated in 13 heroin addicts and 14 normal control subjects. The study was designed to determine whether continuous opiate administration leads to the development of hypersensitive α2-adrenergic receptors. The peak increments in levels of plasma growth hormone (GH) and β-endorphin induced by clonidine did not differ between heroin addicts and normal control subjects. At no time interval could the clonidine-induced rise in GH levels in addicts be differentiated from that induced by placebo. Clonidine failed to alter plasma prolactin, gonadotropin, or thyrotropin levels in either heroin addicts or controls. Since clonidine's neuroendocrine effects are reportedly due to the activation of postsynaptic α2-adrenoceptors, it appears that (1) continuous opiate use does not lead to the development of hypersensitive α2-adrenergic receptors involved in neuroendocrine mechanisms and (2) brain norepinephrine does not play a role in the regulation of tonic prolactin, gonadotropin, and thyrotropin secretion in man.

KW - clonidine

KW - growth hormone

KW - Heroin addicts

KW - β-endorphin

UR - http://www.scopus.com/inward/record.url?scp=0021723483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021723483&partnerID=8YFLogxK

U2 - 10.1016/0165-1781(84)90077-5

DO - 10.1016/0165-1781(84)90077-5

M3 - Article

C2 - 6097932

AN - SCOPUS:0021723483

VL - 13

SP - 295

EP - 304

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 4

ER -